RIM
TPI

Regent Investment Management’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Regent Investment Management’s Portfolio TPI Stock Details TPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,600
Closed -$8K – 192
2015
Q2 		$8K Hold
16,600
– – ﹤0.01% 182
2015
Q1 		$7K Sell
16,600
-3,652
-18% -$2.07K ﹤0.01% 186
2014
Q4 		$15K Sell
20,252
-5,000
-20% -$2.74K 0.01% 190
2014
Q3 		$16K Hold
25,252
– – 0.01% 180
2014
Q2 		$18K Buy
25,252
+652
+3% +$515 0.01% 187
2014
Q1 		$24K Hold
24,600
– – 0.01% 179
2013
Q4 		$19K Sell
24,600
-7,800
-24% -$7.16K 0.01% 176
2013
Q3 		$24K Hold
32,400
– – 0.02% 162
2013
Q2 		$16K Buy
+32,400
New +$19.1K 0.01% 155

Other funds holding TPI

PAM
Pope Asset Management Memphis, Tennessee $162M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Regent Investment Management's TPI Position: Q3 2015 in Review

Regent Investment Management sold out of TIANYIN PHARMACEUTICAL (TPI) in Q3 2015, closing a stake of 16,600 shares — an estimated $8K sold.

Regent Investment Management first reported a position in TPI in Q2 2013 and held it in 9 quarters. The position peaked at $24K in Q1 2014. 6 funds tracked by Wall St. Rank hold TPI as of Q3 2015.

  • Regent Investment Management reported no remaining TIANYIN PHARMACEUTICAL position as of Q3 2015 after selling out during the quarter.
  • Regent Investment Management sold 16,600 TIANYIN PHARMACEUTICAL shares in Q3 2015, an estimated $8K.
  • Regent Investment Management first reported a position in TIANYIN PHARMACEUTICAL in Q2 2013 and held it in 9 quarters.
  • Regent Investment Management's TIANYIN PHARMACEUTICAL position peaked at $24K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q3 2015.

Based on Regent Investment Management's 13F filing for Q3 2015, filed 16 Oct 2015.